Milestone Pharmaceuticals Inc. SEC filings MIST
Milestone Pharmaceuticals Inc. has 421 filings in SEC EDGAR's recent list, going back to Jul 30, 2007. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 28, 2026 (listing notice). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-3 | Shelf registration | May 13, 2026 | — |
| S-8 | Employee stock plan registration | Aug 12, 2025 | — |
| 424B5 | Prospectus supplement | Jul 14, 2025 | — |
| 424B5 | Prospectus supplement | Jul 11, 2025 | — |
| 424B5 | Prospectus supplement | Mar 18, 2025 | — |
| S-8 | Employee stock plan registration | Mar 13, 2025 | — |
| S-3 | Shelf registration | Nov 12, 2024 | — |
| S-8 | Employee stock plan registration | Nov 12, 2024 | — |
| 424B5 | Prospectus supplement | Mar 1, 2024 | — |
| 424B5 | Prospectus supplement | Feb 28, 2024 | — |
| 424B5 | Prospectus supplement | May 31, 2023 | — |
| S-3 | Shelf registration | May 15, 2023 | — |
| S-8 | Employee stock plan registration | Apr 28, 2023 | — |
| S-8 | Employee stock plan registration | Mar 24, 2022 | — |
| S-3 | Shelf registration | Nov 12, 2021 | — |
| S-3/A | Filing | Oct 28, 2021 | — |
| S-3 | Shelf registration | Jun 25, 2021 | — |
| S-8 | Employee stock plan registration | Mar 29, 2021 | — |
| 424B5 | Prospectus supplement | Oct 26, 2020 | — |
| S-3MEF | Form s-3mef | Oct 22, 2020 | — |
| 424B5 | Prospectus supplement | Oct 22, 2020 | — |
| S-3 | Shelf registration | Aug 20, 2020 | — |
| 424B5 | Prospectus supplement | Jul 29, 2020 | — |
| S-3 | Shelf registration | Jun 19, 2020 | — |
| S-8 | Employee stock plan registration | Mar 6, 2020 | — |
| S-8 | Employee stock plan registration | May 9, 2019 | — |
| 424B4 | Prospectus | May 9, 2019 | — |
| S-1MEF | Filing | May 8, 2019 | — |
| S-1/A | Amended registration statement | Apr 29, 2019 | — |
| S-1 | Registration statement | Apr 12, 2019 | — |
Showing 30 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- MIST (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Quebec, Canada
- Headquarters
- Montreal, Quebec, Canada
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1408443
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.